longtext: 7mhd-pdb

content
HEADER    HYDROLASE/INHIBITOR                     15-APR-21   7MHD
TITLE     THIOESTERASE DOMAIN OF HUMAN FATTY ACID SYNTHASE (FASN-TE) BINDING A
TITLE    2 COMPETITIVE INHIBITOR SBP-7635
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: FATTY ACID SYNTHASE;
COMPND   3 CHAIN: A;
COMPND   4 FRAGMENT: THIOESTERASE;
COMPND   5 SYNONYM: TYPE I FATTY ACID SYNTHASE;
COMPND   6 EC: 3.1.2.14;
COMPND   7 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE   3 ORGANISM_COMMON: HUMAN;
SOURCE   4 ORGANISM_TAXID: 9606;
SOURCE   5 GENE: FASN, FAS;
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS    THIOESTERASE DOMAIN, FATTY ACID SYNTHASE, HYDROLASE-INHIBITOR COMPLEX
EXPDTA    X-RAY DIFFRACTION
AUTHOR    A.E.ALESHIN,L.LAMBERT,R.C.LIDDINGTON,N.COSFORD
REVDAT   1   20-APR-22 7MHD    0
JRNL        AUTH   A.E.ALESHIN,L.LAMBERT,R.C.LIDDINGTON,N.COSFORD
JRNL        TITL   THIOESTERASE DOMAIN OF HUMAN FATTY ACID SYNTHASE (FASN-TE)
JRNL        TITL 2 BINDING A COMPETITIVE INHIBITOR SBP-7635
JRNL        REF    TO BE PUBLISHED
JRNL        REFN
REMARK   2
REMARK   2 RESOLUTION.    2.03 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : REFMAC 5.8.0257
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN
REMARK   3
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 35.93
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   COMPLETENESS FOR RANGE        (%) : 97.9
REMARK   3   NUMBER OF REFLECTIONS             : 16028
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.196
REMARK   3   R VALUE            (WORKING SET) : 0.193
REMARK   3   FREE R VALUE                     : 0.246
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.900
REMARK   3   FREE R VALUE TEST SET COUNT      : 824
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 20
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.03
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.08
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 991
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 81.33
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2830
REMARK   3   BIN FREE R VALUE SET COUNT          : 37
REMARK   3   BIN FREE R VALUE                    : 0.3050
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 2189
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 27
REMARK   3   SOLVENT ATOMS            : 106
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 39.20
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 42.49
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 0.61000
REMARK   3    B22 (A**2) : -1.91000
REMARK   3    B33 (A**2) : 1.31000
REMARK   3    B12 (A**2) : 0.00000
REMARK   3    B13 (A**2) : 0.00000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.
REMARK   3   ESU BASED ON R VALUE                            (A): 0.242
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.197
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.164
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.130
REMARK   3
REMARK   3 CORRELATION COEFFICIENTS.
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.962
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.936
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  2321 ; 0.007 ; 0.013
REMARK   3   BOND LENGTHS OTHERS               (A):  2114 ; 0.001 ; 0.017
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  3158 ; 1.526 ; 1.658
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  4909 ; 1.289 ; 1.577
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   291 ; 6.308 ; 5.000
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   121 ;34.782 ;21.901
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   379 ;15.430 ;15.000
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    16 ;20.184 ;15.000
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   298 ; 0.072 ; 0.200
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  2632 ; 0.008 ; 0.020
REMARK   3   GENERAL PLANES OTHERS             (A):   492 ; 0.002 ; 0.020
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  NCS RESTRAINTS STATISTICS
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  BULK SOLVENT MODELLING.
REMARK   3   METHOD USED : MASK
REMARK   3   PARAMETERS FOR MASK CALCULATION
REMARK   3   VDW PROBE RADIUS   : 1.20
REMARK   3   ION PROBE RADIUS   : 0.80
REMARK   3   SHRINKAGE RADIUS   : 0.80
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK   3  POSITIONS U VALUES : REFINED INDIVIDUALLY
REMARK   4
REMARK   4 7MHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-21.
REMARK 100 THE DEPOSITION ID IS D_1000256263.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 02-MAY-16
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : PH 6.0-8.5
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SSRL
REMARK 200  BEAMLINE                       : BL9-2
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0332
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : NULL
REMARK 200
REMARK 200  DETECTOR TYPE                  : PIXEL
REMARK 200  DETECTOR MANUFACTURER          : DECTRIS PILATUS 6M
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200  DATA SCALING SOFTWARE          : AIMLESS
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 16885
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.000
REMARK 200  RESOLUTION RANGE LOW       (A) : 35.930
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.2
REMARK 200  DATA REDUNDANCY                : 4.500
REMARK 200  R MERGE                    (I) : 0.04900
REMARK 200  R SYM                      (I) : NULL
REMARK 200   FOR THE DATA SET  : 15.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.08
REMARK 200  COMPLETENESS FOR SHELL     (%) : 82.5
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.10
REMARK 200  R MERGE FOR SHELL          (I) : 0.61800
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200   FOR SHELL         : 2.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3TJM
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 37.64
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3 UL OF 8 MG/ML FASN-TE IN 100 MM
REMARK 280  NACL, 50 MM BISTRIS PH 6.0, 10 MM DTT, 0.5 MM OF THE INHIBITOR
REMARK 280  AND 1% DMSO WERE MIXED WITH 0.2 UL OF WELL SOLUTION 10% PEG400,
REMARK 280  50 MM TRIS-CL PH 8.5, 1 MM DTT, 1 MM ETHYLENEDIAMINETETRAACETIC
REMARK 280  ACID DISODIUM SALT (EDTA), 300 MM NACL., VAPOR DIFFUSION,
REMARK 280  SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X+1/2,-Y,Z+1/2
REMARK 290       3555   -X,Y+1/2,-Z+1/2
REMARK 290       4555   X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       26.94300
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       38.72500
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       30.74300
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       38.72500
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       26.94300
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       30.74300
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     GLY A   207
REMARK 465     SER A   208
REMARK 465     GLY A   209
REMARK 465     GLY A   210
REMARK 465     GLY A   211
REMARK 465     GLY A   212
REMARK 465     GLY A   213
REMARK 465     SER A   214
REMARK 465     THR A   215
REMARK 465     GLY A   452
REMARK 465     ALA A   453
REMARK 465     TYR A   454
REMARK 465     GLY A   455
REMARK 465     GLU A   456
REMARK 465     GLU A   503
REMARK 465     HIS A   504
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE
REMARK 500   OE1  GLU A   385     O    HOH A   701              2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    SER A 308     -126.52     59.75
REMARK 500    CYS A 359       76.66   -108.29
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ZEP A 601
DBREF  7MHD A  215   503  UNP    P49327   FAS_HUMAN     2215   2503
SEQADV 7MHD GLY A  207  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD SER A  208  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD GLY A  209  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD GLY A  210  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD GLY A  211  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD GLY A  212  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD GLY A  213  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD SER A  214  UNP  P49327              EXPRESSION TAG
SEQADV 7MHD HIS A  504  UNP  P49327              EXPRESSION TAG
SEQRES   1 A  298  GLY SER GLY GLY GLY GLY GLY SER THR GLN LEU ASN LEU
SEQRES   2 A  298  ARG SER LEU LEU VAL ASN PRO GLU GLY PRO THR LEU MET
SEQRES   3 A  298  ARG LEU ASN SER VAL GLN SER SER GLU ARG PRO LEU PHE
SEQRES   4 A  298  LEU VAL HIS PRO ILE GLU GLY SER THR THR VAL PHE HIS
SEQRES   5 A  298  SER LEU ALA SER ARG LEU SER ILE PRO THR TYR GLY LEU
SEQRES   6 A  298  GLN CYS THR ARG ALA ALA PRO LEU ASP SER ILE HIS SER
SEQRES   7 A  298  LEU ALA ALA TYR TYR ILE ASP CYS ILE ARG GLN VAL GLN
SEQRES   8 A  298  PRO GLU GLY PRO TYR ARG VAL ALA GLY TYR SER TYR GLY
SEQRES   9 A  298  ALA CYS VAL ALA PHE GLU MET CYS SER GLN LEU GLN ALA
SEQRES  10 A  298  GLN GLN SER PRO ALA PRO THR HIS ASN SER LEU PHE LEU
SEQRES  11 A  298  PHE ASP GLY SER PRO THR TYR VAL LEU ALA TYR THR GLN
SEQRES  12 A  298  SER TYR ARG ALA LYS LEU THR PRO GLY CYS GLU ALA GLU
SEQRES  13 A  298  ALA GLU THR GLU ALA ILE CYS PHE PHE VAL GLN GLN PHE
SEQRES  14 A  298  THR ASP MET GLU HIS ASN ARG VAL LEU GLU ALA LEU LEU
SEQRES  15 A  298  PRO LEU LYS GLY LEU GLU GLU ARG VAL ALA ALA ALA VAL
SEQRES  16 A  298  ASP LEU ILE ILE LYS SER HIS GLN GLY LEU ASP ARG GLN
SEQRES  17 A  298  GLU LEU SER PHE ALA ALA ARG SER PHE TYR TYR LYS LEU
SEQRES  18 A  298  ARG ALA ALA GLU GLN TYR THR PRO LYS ALA LYS TYR HIS
SEQRES  19 A  298  GLY ASN VAL MET LEU LEU ARG ALA LYS THR GLY GLY ALA
SEQRES  20 A  298  TYR GLY GLU ASP LEU GLY ALA ASP TYR ASN LEU SER GLN
SEQRES  21 A  298  VAL CYS ASP GLY LYS VAL SER VAL HIS VAL ILE GLU GLY
SEQRES  22 A  298  ASP HIS ARG THR LEU LEU GLU GLY SER GLY LEU GLU SER
SEQRES  23 A  298  ILE ILE SER ILE ILE HIS SER SER LEU ALA GLU HIS
HET    ZEP  A 601      27
HETNAM     ZEP N,N-DIETHYL-4-{2-[(2-FLUOROPHENYL)METHYL]-1,3-THIAZOL-
HETNAM   2 ZEP  4-YL}BENZENE-1-SULFONAMIDE
FORMUL   2  ZEP    C20 H21 F N2 O2 S2
FORMUL   3  HOH   *106(H2 O)
HELIX    1 AA1 ASN A  218  LEU A  222  5                                   5
HELIX    2 AA2 THR A  254  VAL A  256  5                                   3
HELIX    3 AA3 PHE A  257  LEU A  264  1                                   8
HELIX    4 AA4 SER A  281  ARG A  294  1                                  14
HELIX    5 AA5 SER A  308  SER A  326  1                                  19
HELIX    6 AA6 SER A  340  ALA A  353  1                                  14
HELIX    7 AA7 CYS A  359  GLN A  374  1                                  16
HELIX    8 AA8 GLU A  379  LEU A  388  1                                  10
HELIX    9 AA9 GLY A  392  HIS A  408  1                                  17
HELIX   10 AB1 ASP A  412  GLN A  432  1                                  21
HELIX   11 AB2 ASN A  463  VAL A  467  5                                   5
HELIX   12 AB3 GLU A  486  LEU A  501  1                                  16
SHEET    1 AA1 7 LEU A 231  ARG A 233  0
SHEET    2 AA1 7 THR A 268  LEU A 271 -1  O  GLY A 270   N  MET A 232
SHEET    3 AA1 7 LEU A 244  VAL A 247  1  N  LEU A 246   O  LEU A 271
SHEET    4 AA1 7 ARG A 303  TYR A 307  1  O  ALA A 305   N  VAL A 247
SHEET    5 AA1 7 SER A 333  PHE A 337  1  O  SER A 333   N  VAL A 304
SHEET    6 AA1 7 VAL A 443  ALA A 448  1  O  MET A 444   N  LEU A 336
SHEET    7 AA1 7 VAL A 472  ILE A 477  1  O  SER A 473   N  LEU A 445
CISPEP   1 GLY A  300    PRO A  301          0        -0.92
CISPEP   2 SER A  326    PRO A  327          0        -1.33
SITE     1 AC1 15 ILE A 250  SER A 308  TYR A 343  VAL A 344
SITE     2 AC1 15 TYR A 347  TYR A 351  ARG A 352  ALA A 363
SITE     3 AC1 15 GLU A 366  ALA A 367  TYR A 424  LEU A 427
SITE     4 AC1 15 GLU A 431  HIS A 481  HOH A 720
CRYST1   53.886   61.486   77.450  90.00  90.00  90.00 P 21 21 21    4
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.018558  0.000000  0.000000        0.00000
SCALE2      0.000000  0.016264  0.000000        0.00000
SCALE3      0.000000  0.000000  0.012912        0.00000
TER    2242      ALA A 502
MASTER      297    0    1   12    7    0    4    6 2322    1   27   23
END